Mission: Cure


blood samplesMission: Cure is using outcome-based financing and impact investing to demonstrate a new model for curing disease, beginning with chronic pancreatitis.

Currently in the planning stage, Mission: Cure Pancreatitis will get commitments from impact philanthropists and from those who bear the costs of chronic pancreatitis to pay for significant improvements in patient outcomes over a defined timeframe. These incentives for patient outcomes will complement existing market incentives for development of therapies for orphan diseases. Impact investors will then invest in a portfolio of strategies designed to achieve the agreed-upon patient outcomes.

Repurposing of existing drugs, devices and nutraceuticals will be a central strategy to quickly and affordably improve patients’ lives. Mission: Cure Pancreatitis will convene and support a coalition of interested parties, including investors, government and private outcome payers, patients and the experts researching and treating people regularly, to problem-solve and project-manage to achieve the outcomes on schedule.

If successful, the impact investors will not only have helped improve people’s lives but will also earn a financial return on their investment. Looking to the future, Mission: Cure will demonstrate a viable model for curing a disease in a world where precision medicine, value-based payment and impact investing are the norm.


Meet Megan Golden, co-founder of Mission: Cure

Contact Megan




Donate Today



Sign up for our eNewsletter today!


First Name


Cures Within Reach

Illinois Science+Technology Park

8025 Lamon Avenue, Suite 440

Skokie, IL 60077




Saturday the 21st. copyright 2015 Cures Within Reach.